↓ Skip to main content

Dove Medical Press

Article Metrics

Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
46 Mendeley
Title
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives
Published in
Therapeutics and Clinical Risk Management, July 2014
DOI 10.2147/tcrm.s50002
Pubmed ID
Authors

Artur Dziewierz, Tomasz Rakowski, Dariusz Dudek

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 15%
Researcher 6 13%
Other 5 11%
Student > Doctoral Student 4 9%
Student > Master 4 9%
Other 8 17%
Unknown 12 26%
Readers by discipline Count As %
Medicine and Dentistry 20 43%
Agricultural and Biological Sciences 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Biochemistry, Genetics and Molecular Biology 2 4%
Business, Management and Accounting 1 2%
Other 0 0%
Unknown 14 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2014.
All research outputs
#11,342,681
of 19,016,777 outputs
Outputs from Therapeutics and Clinical Risk Management
#563
of 1,158 outputs
Outputs of similar age
#96,472
of 203,424 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 11 outputs
Altmetric has tracked 19,016,777 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,158 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,424 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.